Milestone Scientific : Hosts Webcast with Top Key Opinion Leader to Discuss Advantages of the CompuFlo™ Epidural Instrument

Contact:

David Waldman or Natalya Rudman Crescendo Communications, LLC Email: mlss@crescendo-ir.com

Tel: 212-671-1020

Dr. Ralf E. Gebhard is a Professor in the Department of Anesthesiology, Perioperative Medicine and Pain Management at the University of Miami. He also is the Chief of the Division of Acute Pain Management and Regional Anesthesia and serves as Associate Vice Chairman for Clinical Research. Dr. Gebhard joined the University of Miami in 2006 coming from The University of Texas‐Houston. In addition to his expertise in the area of Acute Pain Management, Dr. Gebhard has also proven himself to be an outstanding clinical researcher and scientist. He has conducted more than 40 clinical trials as a Principal Investigator and has received significant grants to support his research. His area of particular interest is related to peripheral nerve block safety and complications, as well as, acute pain management in the pediatric population Dr. Gebhard has published multiple book chapters and over 30 peer reviewed articles. He currently serves as a reviewer for numerous journals including Anesthesiology, Anesthesia and Analgesia and Regional Anesthesia and Pain Medicine. He is a frequent speaker at both national and international meetings and is considered an international expert in regional anesthesia and acute pain management.

Milestone Scientific Inc. (MLSS) is a leading medical research and development company that designs and patents innovative injection technology. Milestone's computer-controlled systems make injections precise, efficient, and virtually painless. For more information please visit our website: www.milestonescientific.com.

The presentation contains forward-looking statements regarding the advantages of the CompuFlo Epidural Instrument. These statements represent the views and opinions of the presenter and may not represent the prevalent views and opinions of dental professionals, presently or in the future. The views and opinions of the presenter may be affected by future results of dental professionals utilizing the device, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2016. The forward- looking statements in this presentation are based upon reasonable beliefs as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason. Please note that, from time to time, Milestone compensates its key opinion leaders for participation in and/or attendance at sponsored events on its behalf. Any such compensation is made without regard to the opinions and conclusions expressed by any such individual.

# # #